HKD 3.05
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.65 Billion CNY | -0.08% |
2022 | 2.65 Billion CNY | 116.46% |
2021 | 1.22 Billion CNY | 16.34% |
2020 | 1.05 Billion CNY | 99.5% |
2019 | 529.05 Million CNY | 3.89% |
2018 | 509.25 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 2.14 Billion CNY | -19.27% |
2024 Q2 | 2.14 Billion CNY | 0.0% |
2023 Q3 | 2.41 Billion CNY | -2.61% |
2023 FY | 2.65 Billion CNY | -0.08% |
2023 Q2 | 2.47 Billion CNY | 7.88% |
2023 Q1 | 2.29 Billion CNY | -13.62% |
2023 Q4 | 2.65 Billion CNY | 10.1% |
2022 Q2 | 1.68 Billion HKD | 0.0% |
2022 Q3 | 2.36 Billion CNY | 40.74% |
2022 Q4 | 2.65 Billion CNY | 12.27% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Life Healthcare Group Limited | 70.08 Million HKD | -3689.455% |
China Biotech Services Holdings Limited | 171.63 Million HKD | -1447.367% |